SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 303 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $475,000 | +79.9% | 2,750 | +19.9% | 0.01% | +150.0% |
Q4 2014 | $264,000 | -90.2% | 2,293 | -86.7% | 0.00% | -92.3% |
Q3 2014 | $2,684,000 | +291.3% | 17,194 | +208.9% | 0.05% | +372.7% |
Q2 2014 | $686,000 | -40.8% | 5,566 | -50.2% | 0.01% | -21.4% |
Q1 2014 | $1,158,000 | +225.3% | 11,181 | +110.2% | 0.01% | +180.0% |
Q3 2013 | $356,000 | – | 5,319 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |